Literature DB >> 9145375

Isolation and structure elucidation of the major degradation products of cefaclor formed under aqueous acidic conditions.

S W Baertschi1, D E Dorman, J L Occolowitz, M W Collins, L A Spangle, G A Stephenson, L J Lorenz.   

Abstract

The aqueous acidic degradation of the oral cephalosporin cefaclor was investigated. A number of degradation products were isolated and characterized. The degradation products can be loosely classified into three categories: thiazole derivatives, pyrazine derivatives, and simple hydrolysis or rearrangement products. Degradation pathways are proposed that involve (1) hydrolysis of the beta-lactam carbonyl with subsequent rearrangement, (2) ring contraction of the six-membered cephem nucleus to five-membered thiazole derivatives through an episulfonium ion intermediate, and (3) attack of the primary amine of the phenylglycyl side chain on the "masked aldehyde" at carbon-6 to form fluorescent substituted pyrazines.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9145375     DOI: 10.1021/js960427x

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  2 in total

1.  Penetration of cefaclor into the interstitial space fluid of skeletal muscle and lung tissue in rats.

Authors:  A De La Peña; T Dalla Costa; J D Talton; E Rehak; J Gross; U Thyroff-Friesinger; A I Webb; M Müller; H Derendorf
Journal:  Pharm Res       Date:  2001-09       Impact factor: 4.200

2.  Rescue of Transgenic Alzheimer's Pathophysiology by Polymeric Cellular Prion Protein Antagonists.

Authors:  Erik C Gunther; Levi M Smith; Mikhail A Kostylev; Timothy O Cox; Adam C Kaufman; Suho Lee; Ewa Folta-Stogniew; George D Maynard; Ji Won Um; Massimiliano Stagi; Jacqueline K Heiss; Austin Stoner; Geoff P Noble; Hideyuki Takahashi; Laura T Haas; John S Schneekloth; Janie Merkel; Christopher Teran; Zahra K Naderi; Surachai Supattapone; Stephen M Strittmatter
Journal:  Cell Rep       Date:  2019-01-02       Impact factor: 9.423

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.